EPIC Program Annual Data Tables 2005-2006: Table VII

Table VII
Ten Most Frequently Purchased Types of Drugs
by Therapeutic Classification*
Therapeutic Class** Number
of Claims
Percent
of Claims
EPIC
Payments
Number of
Participants
Total***4,775,14441.46%$330,656,167
BETA-ADRENERGIC BLOCKING AGENT920,4987.99%$27,873,095169,592
HMG-COA REDUCTASE INHIBITORS694,7976.03%$97,333,548159,412
ANGIOTENSIN-CONVERTING ENZYME572,1034.97%$19,923,456112,460
PROTON-PUMP INHIBITORS415,8673.61%$78,230,749100,617
DIHYDROPYRIDINES393,1363.41%$29,525,35681,323
ANTIDEPRESSANTS386,7593.36%$27,471,33674,306
ANGIOTENSIN II RECEPTOR ANTAGO369,1253.20%$29,651,50878,518
OPIATE AGONISTS354,2603.08%$13,914,07493,487
LOOP DIURETICS338,4092.94%$2,152,89876,808
THYROID AGENTS330,1902.87%$4,580,14764,287

* Table VII provides the percent of adjudicated claims for the program year (October 1, 2005 through September 30, 2006) as they fall into particular categories of Therapeutic Class.

** American Hospital Formulary Service® (AHFS) Pharmacologic-Therapeutic Classification.

*** This report contains the top ten drug classes; additional drug classes comprise the remainder of claims up to 100.00%.